Resource Centers
- Adverse Drug Events Reporting
- Cardiovascular Health Management in a Multicultural Society
- Electronic Health Records
- Geriatric Care
- Healthcare Reform
- Health Diversity
- Hypertension
- Integrative Medicine
- Obesity and Weight Management
- Pain Management: Pharmacologic Approaches
- Substance Abuse and Addiction
- More »
Slideshow
- Obesity May Top Hypertension as Risk Factor for LA Enlargement
- DE-MRI Shows Which Myocardial Injury Is Irreversible
- Echocardiographic Evidence of Pulmonary Hypertension Frequently Does Not Trigger Referral to a Specialist
- Adult Primary Care Visit Frequency, Quality, and Duration Increasing
- Alert Cordis Crossover Sheath Introducer Recalled
Internal Medicine Journals
Medscape Community Resources
Related Blogs
- Opening Day
- Opening Day
- The drospirenone Debate
- Baseline PSA at Age 40 Reinforced by AUA: What Happened to Evidence Based Medicine?
- ECMO and peramivir for severe H1N1
- Sponsored Blog
- Multiplicity and Scientific Inference
POLL
In a BMJ editorial published last month, mandatory screening of all electively admitted patients for MRSA in UK hospitals was criticized for being "unethical" and "unjustified," citing it as potentially harmful because of a potential delay in treatment. Do you favor or oppose mandatory screening for MRSA in hospitalized patients?
Expert Video Blogs
- Sponsored Blog
- Multiplicity and Scientific Inference
- A Treatment Option for Atrial Fibrillation
- A single medication with 4 indications
- ABILIFY® (aripiprazole)
- ADHD treatment: Efficacy, insights, and dosing
- Atrial Fibrillation Condition Site
- CRESTOR® (rosuvastatin calcium)
- Carac® (fluorouracil cream 0.5%)
- Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension
- Clinical Management Center
- DanActive® and ACTIVIA® Information Center
- Diabetes in America
- ENABLEX® (darifenacin) Extended-Release Tablets 7.5 mg or 15 mg
- Epilepsy360: Connections in Care
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- GEODON® (ziprasidone HCI)
- IL-6 and Rheumatoid Arthritis
- Institute for Advances in Point-of-Care Testing
- LEVAQUIN® (levofloxacin) tablets/injection
- LOVAZA® (omega-3-acid ethyl esters)
- NUCYNTA™ (tapentadol)
- Navigenics® Genetic Risk Assessment Services
- Neuroendocrine tumors: Increasing in incidence and easy to overlook
- OPTIMAL Forum™
- Onglyza™ (saxagliptin) InfoSite
- PREMARIN® (conjugated estrogens tablets, USP)
- PRISTIQ® (desvenlafaxine)
- ProAir® HFA
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- QuickVue® Influenza A+B Test
- REBIF® (interferon beta-1a)
- Reclast® (zoledronic acid) injection
- Risk of Osteoporosis
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
- TOVIAZ® (fesoterodine fumarate)
- The Pain Institute
- VESIcare (solifenacin succinate) tablets
- VIGAMOX® solution
- Vyvanse (lisdexamfetamine dimesylate)
- XYZAL® (levocetirizine dihydrochloride)
Latest from SHM at
Medscape.com/shm
Medscape.com/shm
Latest from The Medical Home at
Medscape.com/PCMH
Medscape.com/PCMH
Advisory Board
- Robert M. Centor, MD
- Melissa Clarke, MD
- David C. Dale, MD, FACP
- James J. Foody, MD, FACP
- R. Brian Haynes, MD, PhD, MACP
- Joseph M. Li, MD
- Daniel Z. Sands, MD, MPH
- Mark E. Williams, MD
Site Editorial Director
